Stockscreener 앱 받기
43.70
4.07%
1.71
시간 외 거래:
43.03
-0.67
-1.53%
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
Can Vaxcyte Inc. (5VA) stock sustain double digit ROE2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com
Vaxcyte (NASDAQ:PCVX) Shares Up 4.6%Time to Buy? - MarketBeat
Is Vaxcyte Inc a good long term investmentExit Strategy Tips & Turn Market Volatility into Wealth - earlytimes.in
Is Vaxcyte Inc. (5VA) stock cheap by valuation metricsQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Will Vaxcyte Inc. see short term momentumMarket Activity Report & Daily Profit Maximizing Trade Tips - newser.com
Why Vaxcyte Inc. (5VA) stock is a strong analyst pickJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
Thermo Fisher Scientific’s Valuation: Assessing the Impact of Its $1 Billion Vaxcyte Vaccine Manufacturing Deal - Yahoo Finance
Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX) - Yahoo Finance
What consensus target says about Vaxcyte Inc. (5VA) stockBuy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Vaxcyte Inc. (5VA) stock sustain dividend payouts2025 Retail Activity & Safe Entry Point Alerts - newser.com
111 Capital Takes Position in Vaxcyte, Inc. $PCVX - MarketBeat
PCVX Stock Price and Chart — NASDAQ:PCVX - TradingView
Will breakout in Vaxcyte Inc. lead to full recoveryExit Point & Reliable Price Breakout Alerts - newser.com
Is Vaxcyte Inc. (5VA) stock attractive post correctionJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - newser.com
What candlestick patterns are forming on Vaxcyte Inc.2025 Macro Impact & Free Daily Entry Point Trade Alerts - newser.com
Vaxcyte’s Strategic Moves: Impact on PCVX - StocksToTrade
BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $134 - 富途牛牛
Why Vaxcyte Inc. stock is in analyst buy zoneWeekly Earnings Recap & Safe Entry Point Identification - newser.com
Earnings visualization tools for Vaxcyte Inc.Swing Trade & AI Driven Stock Price Forecasts - newser.com
A Look at Vaxcyte’s (PCVX) Valuation Following $1 Billion Thermo Fisher Manufacturing Deal - simplywall.st
Vaxcyte Inc.’s volatility index tracking explainedWeekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Is Vaxcyte Inc. (5VA) stock a buy before earnings results2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production - MSN
What analysts say about Vaxcyte Inc 5VA stockMarket Rumors and News & Collaborate and Win Together - earlytimes.in
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown - Sahm
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services - Sahm
Vaxcyte signs $1 billion manufacturing deal with Thermo Fisher By Investing.com - Investing.com Nigeria
Vaxcyte, Inc. to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services - MarketScreener
What Does Wall Street Think About Vaxcyte (PCVX)? - MSN
Vaxcyte Signs 15-Year Agreement with Patheon - TipRanks
Vaxcyte to Establish Fill-Finish Manufacturing in North - GlobeNewswire
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown - Benzinga
Vaxcyte to Expand Fill-Finish Manufacturing Capacity in US; Shares Up Pre-Bell - MarketScreener
Vaxcyte to Partner with Thermo Fisher to Increase Vaccine Production in U.S. - MarketScreener
Vaxcyte signs $1 billion manufacturing deal with Thermo Fisher - Investing.com
5.74%
자본화:
|
볼륨(24시간):